Strategies in treating male breast cancer

Bibliography

• CRICHLOW RW, GALT SW: Male breast cancer. Surg. Clin. North Am. (1990) 70(5):1165-1177.
   PubMed Web of Science ®Google Scholar
• DONEGAN WL, REDLICH PN: Breast cancer in men. Surg. Clin. North Am. (1996) 76:343-363.
   PubMed Web of Science ®Google Scholar
• FENTIMAN IS, FOURQUET A, HORTOBAGYI G: Male breast cancer. Lancet (2006) 367:595-604.
   PubMed Web of Science ®Google Scholar
• GENNARI R, CURIGLIANO G, JERECZEC-FOSSA B et al.: Male breast cancer: a special therapeutic problem. Anything new? Int. J. Oncol. (2004) 24:663-670.
   PubMed Web of Science ®Google Scholar
• GOSS PE, REID C, PINTILIE M et al.: Male breast carcinoma. A review of 229 patients who presented to the Princess Margaret Hospital during 40 years:1955-1996. Cancer (1999) 85:629-639.
   PubMed Web of Science ®Google Scholar
• GUINEE VF, OLSSON H, MOLLER T et al.: The prognosis of breast cancer in males. A report of 335 cases. Cancer (1993) 71:154-161.
   PubMed Web of Science ®Google Scholar
• RIBEIRO GG, SWINDELL R, HARRIS M et al.: A review of the management of the male breast carcinoma based on an analysis of 420 treated cases. Breast (1996) 5:141-146.
   Web of Science ®Google Scholar
• DONEGAN WL, REDLICH PN, LANG PJ, GALL MT: Carcinoma of the breast in males: a multi institutional survey. Cancer (1998) 83:498-509.
   PubMed Web of Science ®Google Scholar
• CUTULI B, LACROZE M, DILHUYDY JM et al.: Male breast cancer. Results of the treatments and prognostic factors in 397 cases. Eur. J. Cancer (1995) 31A:1960-1964.
   PubMed Web of Science ®Google Scholar
• CUTULI B, VELTEN M, DILHUYDY JM et al.: Male breast cancer: result of the treatment and prognostic factors in 690 cases. Int. J. Rad. Oncol. Biol. Phys. (1998) 42(Suppl. 1):Abstr. 2056.
   Google Scholar
• SCHEIKE O: Male breast cancer. 5. Clinical manifestations in 257 cases in Denmark. Br. J. Cancer (1973) 28:552-561.
   PubMed Web of Science ®Google Scholar
• EWERTZ M, HOLMBERG L, TRETLI S, PEDERSEN BV, KRISTENSEN A: Risk factors for male breast cancer. A case control study from Scandinavia. Acta Oncol. (2001) 40:467-471.
   PubMed Web of Science ®Google Scholar
• KRAUSE W: Male breast cancer: an andrological disease: risk factors and diagnosis. Andrologia (2004) 36:346-354.
   PubMed Web of Science ®Google Scholar
• ROSENBLATT KA, THOMAS DB, MCTIERNAN A et al.: Breast cancer in men: aspects of familial agregation. J. Natl Cancer Inst. (1991) 12:849-854.
   Google Scholar
• SASCO AJ, LOWENFELS AB, PASKER-DE JONG P: Review article: epidemiology of male breast cancer. A meta-analysis of published case-control studies and discussion of selected aetiological factors. Int. J. Cancer (1993) 53:538-549.
   PubMed Web of Science ®Google Scholar
• CIATTO S, IOSSA A, BONARDI R, PACINI P: Male breast carcinoma: review of a multicenter series of 150 cases. Tumori (1990) 76:555-558.
   PubMed Web of Science ®Google Scholar
• SALVADORI B, SACCOZZI R, MANZARI A et al.: Prognosis of breast cancer in males: an analysis of 170 cases. Eur. J. Cancer (1994) 30A:930-935.
   PubMed Web of Science ®Google Scholar
• STIERER M, ROSEN H, WEITENSFELDER W et al.: Male breast cancer: Austrian experience. World J. Surg. (1995) 19:687-693.
   PubMed Web of Science ®Google Scholar
• BEN DHIAB T, BOUZID T, GAMOUDI A et al.: Male breast cancer: about 123 cases collected at the Institute Salah-Azoiz of Tunis from 1979 to 199. Bull. Cancer (2005) 92:281-285.
   PubMed Web of Science ®Google Scholar
• HULTBORN R, FRIBERG S, HULTBORN KA: Male breast carcinoma. A study of the total material reported to the Swedish cancer registry 1958-1967 with respect to clinical and histopathological parameters. Acta Oncol. (1987) 26:241-256.
   PubMed Web of Science ®Google Scholar
• STALSBERG H, THOMAS DB, ROSENBLATT KA et al.: Histologic types and hormone receptors in breast cancer in United States men: a population-based study in 282 men. Cancer Causes Control (1993) 4:143-151.
   PubMed Web of Science ®Google Scholar
• CAMUS MF, JOSHI MG, MACKAREM G et al.: Ductal carcinoma in situ of the male breast. Cancer (1994) 74:1289-1293.
   PubMed Web of Science ®Google Scholar
• CUTULI B, DILHUYDY JM, DE LA FONTAN B: Ductal carcinoma in situ of the male breast: analysis of 31 cases. Eur. J. Cancer (1997) 33:35-38.
   PubMed Web of Science ®Google Scholar
• HITTMAIR AP, LININGER RA, TAVASSOLI FA: Ductal carcinoma in situ (DCIS) in the male breast. A morphologic study of 84 cases of pure DCIS and 30 cases of DCIS associated with invasive carcinoma. A preliminary report. Cancer (1998) 83:2139-2149.
   PubMed Web of Science ®Google Scholar
• ANDERSON WF, DEVESA SS: In situ male breast carcinoma in the surveillance, epidemiology, and end results database of the National Cancer Institute. Cancer (2005) 104:1733-1741.
   PubMed Web of Science ®Google Scholar
• MACDONALD G, PALTIEL C, OLIVOTTO IA, TYLDESLEY S: A comparative analysis of radiotherapy use and patient outcome in males and females with breast cancer. Ann. Oncol. (2005) 16:1442-1448.
   PubMed Web of Science ®Google Scholar
• MUIR D, KANTHAN R, KANTHAN SC: Male versus female breast cancer. Arch. Pathol. Lab. Med. (2003) 127:36-41.
   PubMed Web of Science ®Google Scholar
• OLSSON H: Estrogen receptors content in malignant breast tumors in men. A review. J. Mammary Gland Biol. Neoplasia (2000) 5:283-287.
   PubMed Web of Science ®Google Scholar
• GIORDANO SH, PERKINS GH, BROGLIO K et al.: Adjuvant systemic therapy for male breast carcinoma. Cancer (2005) 104:2359-2364.
   PubMed Web of Science ®Google Scholar
• HILL A, YAGMOUR Y, TRAN KN et al.: Localized male breast carcinoma and family history. An analysis of 142 patients. Cancer (1999) 86:821-825.
   PubMed Web of Science ®Google Scholar
• BORGEN PI, WONG GY, VLAMIS V et al.: Current management of male breast cancer. A review of 104 cases. Ann. Surg. (1992) 215:451-459.
   PubMed Web of Science ®Google Scholar
• SCHAAPVELD M, DE VRIES EG, VAN DE GRAAF WT et al.: The prognostic effect of the number of histologically examined axillary lymph nodes in breast cancer: stage migration o rage association? Ann. Surg. Oncol. (2006) 13:465-474.
   PubMed Web of Science ®Google Scholar
• LYMANN GH, GIULIANO AE, SOMERFIELD MR et al.: American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early stage breast cancer. J. Clin. Oncol. (2005) 23:7703-7720.
   PubMed Web of Science ®Google Scholar
• GOYAL A, HORGAN K, KISSIN M et al.: Sentinel lymph node biopsy in male breast cancer patients. Eur. J. Surg. Oncol (2004) 30:480-483.
   PubMed Web of Science ®Google Scholar
• DE CICCO C, BAIO SM, VERONESI P et al.: Sentinel node biopsy in male breast cancer. Nucl. Med. Commun. (2004) 25:139-143.
   PubMed Web of Science ®Google Scholar
• PORT ER, FEY JV, CODY HS III, BORGEN PI: Sentinal lymph node biopsy in patients with male breast carcinoma. Cancer (2001) 91:319-323.
   PubMed Web of Science ®Google Scholar
• ERLICHMAN C, MURPHY KC, ELHAKIM T: Male breast cancer: a 13 year review of 89 patients. J. Clin. Oncol. (1984) 2:903-909.
   PubMed Web of Science ®Google Scholar
• EL OMARI-ALAOUI H, LAHDIRI I, NEJJAR I et al.: Male breast cancer. A report of 71 cases. Cancer Radiother. (2002) 6:349-351.
   PubMedGoogle Scholar
• CHAKRAVARTHY A, KIM CR: Post mastectomy radiation in male breast cancer. Radiother. Oncol. (2002) 65:99-103.
   PubMed Web of Science ®Google Scholar
• IZQUIERDO MA, ALONSO C, DE ANDRES L et al.: Male breast cancer. Report of a series of 50 cases. Acta Oncol. (1994) 33:767-771.
   PubMed Web of Science ®Google Scholar
• SCHUCHARDT U, SEEGENSCHMIEDT MH, KIRSCHNER MJ, RENNER H, SAUER R: Adjuvant radiotherapy for breast carcinoma in men: a 20-year clinical experience. Ann J. Clin. Oncol. (1996) 19:330-336.
   PubMed Web of Science ®Google Scholar
• STRANZL H, MAYER R, QUEHENBERGER F et al.: Adjuvant radiotherapy in male breast cancer. Radiother. Oncol. (1999) 53:29-35.
   PubMed Web of Science ®Google Scholar
• ZABEL A, MILKER-ZABEL S, ZUNA I, WANNENMACHER M, DEBUS J: External beam radiotherapy in the treatment of male breast carcinoma: patterns of failure in a simple institute experience. Tumori (2005) 91:151-155.
   PubMed Web of Science ®Google Scholar
• KURTZ J: The curative role of radiotherapy in the treatment of operable breast cancer. Eur. J. Cancer (2002) 38:1961-1974.
   PubMed Web of Science ®Google Scholar
• RECHT A, EDGE SB: Evidence-based indications for postmastectomy irradiation. Surg. Clin. N. Am. (2003) 83:995-1013.
   PubMed Web of Science ®Google Scholar
• PIERCE LJ: The use of radiotherapy after mastectomy: a review of the literature. J. Clin. Oncol. (2005) 23:1706-1717.
   PubMed Web of Science ®Google Scholar
• TRUONG PT, WOODWARD WA, BUCHHOLZ TA: Optimizing locoregional control and survival for women with breast cancer: a review of current developments in post mastectomy radiotherapy. Expert Rev. Anti-Cancer Ther. (2006) 6:205-216.
   PubMed Web of Science ®Google Scholar
• RAGAZ J, OLIVOTTO IA, SPINELLI JJ et al.: Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia Randomized trial. J. Natl Cancer Inst. (2005) 97:116-126.
   PubMedGoogle Scholar
• NIELSEN HM, OVERGAARD M, GRAU C, JENSEN AR, OVERGAARD J: Study of failure pattern amon high-risk breast cancer patients wit hor without post mastectomy radiotherapy in addition to systemic therapy: long term results from the Danish Breast Cancer Cooperative Group DBCG 82b and c randomized studies. J. Clin. Oncol. (2006) 24:2268-2275.
   PubMed Web of Science ®Google Scholar
• WALLGREN A, BONETTI M, GELBER RD et al.: Risk factors for locoregional recurrence among breast cancer patients; results from International Breast Cancer Study Group Trials I through VII. J. Clin. Oncol. (2003) 21:1205-1213.
   PubMed Web of Science ®Google Scholar
• KATZ A, BUCHOLZ TA, THAMES H et al.: Recursive partitioning analysis of locoregional recurrence patterns following mastectomy: implications for adjuvant irradiation. Int. J. Radiat. Oncol. Biol. Phys. (2001) 50:397-400.
   PubMed Web of Science ®Google Scholar
• TRUONG PT, BERTHELET E, LEE J, KADER HA, OLIVOTTO IA: The prognostic significance of the percentage of positive/dissected axillary lymph nodes in breast cancer recurrence and survival in patients with one to three positive axillary lymph nodes. Cancer (2005) 103:2006-2014.
   PubMed Web of Science ®Google Scholar
• EARLY BREAST CANCER TRIALIST COLLABORATIVE GROUP (EBCTCG): Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomized trials. Lancet (2005) 365:2087-2106.
   Web of Science ®Google Scholar
• GEBSKI V, LAGLEVA M, KEECH A, SIMES J, LANGLANDS AO: Survival effects of postmastectomy adjuvant radiation therapy using biologically equivalent doses: a clinical prospective. J. Natl Cancer Inst. (2006) 98:26-38.
   PubMedGoogle Scholar
• RIBEIRO GG: Male breast carcinoma. A review of 301 cases from the Christie Hospital and Holt Radium Institute, Manchester Br. J. Cancer (1985) 51:115-119.
   Web of Science ®Google Scholar
• RAVANDI-KASHANI F, HAYES TG: Male breast cancer: a review of the literature. Eur. J. Cancer (1998) 34:1341-1347.
   PubMed Web of Science ®Google Scholar
• IREDALE R, BRAIN K, WILLIAMS B, FRANCE E, GRAY J: The experiences of men with breast cancer in the United Kingdom. Eur. J. Cancer (2006) 42:334-341.
   PubMed Web of Science ®Google Scholar
• ANELLI TF, ANELLI A, TRAN KN, LEBWOHL DE, BORGEN PI: Tamoxifen administration in association with a high rate of treatment-limiting symptoms in male breast cancer patients. Cancer (1994) 74:74-77.
   PubMed Web of Science ®Google Scholar
• NAHLEH ZA: Hormonal therapy for male breast cancer: a different approach for a different disease. Cancer Treat. Rev. (2006) 32:101-105.
   PubMed Web of Science ®Google Scholar
• MUNOZ DE TORO MM, MAFFINI MV, KASS L, LUQUE EH: Proliferative activity and steroid hormone receptors status in male breast carcinoma. J. Steroid Biochem. Mal. Biol. (1998) 67:333-9.
   PubMed Web of Science ®Google Scholar
• MURPHY CE, CARDER PJ, LANDSDOWN MR, SPEIRS V: Steroid hormone receptor expression in male breast cancer. Eur. J. Surg. Oncol (2006) 32:44-47.
   PubMed Web of Science ®Google Scholar
• GIORDANO SH, HORTOBAGYI GN: Leuprolide acetate plus aromatase inhibition for male breast cancer. J. Clin. Oncol. (2006) 21:e42-e43.
   Google Scholar
• GIORDANO SH, VALERO V, BUZDAR AU, HORTOBAGYI GN: Efficacy of anastrozole in male breast cancer. Ann. J. Clin. Oncol. (2002) 25:235-237.
   PubMed Web of Science ®Google Scholar
• ZABOLOTNY BP, ZALAI CV, MATERISSIAN SH: Successful use of letrozole in male breast cancer: a case report and review of hormonal therapy for male breast cancer. J. Surg. Oncol. (2005) 90:26-30.
   PubMed Web of Science ®Google Scholar
• BAGLEY CS, WESLEY MN, YOUNG RC, LIPPMAN ME: Adjuvant chemotherapy in males with cancer of the breast. Am. J. Clin. Oncol. (1987) 10:55-60.
   PubMed Web of Science ®Google Scholar
• PATEL HZ, BUZDAR AV, HORTOBAGY GN: Role of adjuvant chemotherapy in male breast cancer. Cancer (1989) 64:1583-1585.
   PubMed Web of Science ®Google Scholar
• YILDIRIM E, BERBEROGLU U: Male breast cancer: a 22-year experience. Eur. J. Surg. Oncol. (1998) 24:548-552.
   PubMed Web of Science ®Google Scholar
• GIORDANO SH, DUAN Z, KUO YF, HORTOBAGYI GN, GOODWIN JS: Use and outcome of adjuvant chemotherapy in older women with breast cancer. J. Clin. Oncol. (2006) 24:2750-2756.
   PubMed Web of Science ®Google Scholar
• BORGEN PI, SENIE RT, MCKINNON WM, ROSEN PP: Carcinoma of the male breast: analysis of prognosis compared with matched female patients. Ann. Surg. Oncol. (1997) 4:385-388.
   PubMed Web of Science ®Google Scholar
• EARLY BREAST CANCER TRIALIST COLLABORATIVE GROUP (EBCTCG): Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomized trials. Lancet (2005) 365:1687-1717.
   PubMed Web of Science ®Google Scholar
• RUDLOWSKI C, FRIEDRICHS N, FARIDI A et al.: Her-2/neu gene amplification and protein expression in primary male breast cancer. Breast Cancer Res. Treat. (2004) 84:215-223.
   PubMed Web of Science ®Google Scholar
• WANG-RODRIGUEZ J, CROSS K, GALLAGHER S et al.: Male breast carcinoma: correlation of ER, PR, KI-67, Her2-Neu and p53 with treatment and survival. A study of 65 cases. Med. Pathol. (2002) 15:853-861.
   PubMed Web of Science ®Google Scholar
• RAYSON D, ERLICHMAN C, SUMAN VJ et al.: Molecular markers in male breast carcinoma. Cancer (1998) 83:1947-1955.
   PubMed Web of Science ®Google Scholar
• AUVINEN A, CURTIS RE, RON E: Risk of subsequent cancer following breast cancer in men. J. Natl Cancer Inst. (2002) 94:1330-1332.
   PubMedGoogle Scholar
• DONG C, HEMMINKI K: Second primary breast cancer in men. Breast Cancer Res. Treat. (2001) 66:171-172.
   PubMed Web of Science ®Google Scholar
• HEMMINSKI K, SCELO G, BOFFETTA P et al.: Second primary malignancies in patients with male breast cancer. Br. J. Cancer (2005) 92:1288-1292.
   PubMed Web of Science ®Google Scholar
• JOSHI MG, LEE AKC, LODA M et al.: Male breast carcinoma: an evaluation of prognostic factors contributing to a poorer outcome. Cancer (1996) 77:490-498.
   PubMed Web of Science ®Google Scholar
• LOPEZ M, DI LAURO L, LAZZARO B, PAPALDO P: Hormonal treatment of disseminated male breast cancer. Oncology (1985) 42:345-349.
   PubMed Web of Science ®Google Scholar
• TIRELLI U, TUMOLO S, TALAMINI R, VERONESI A et al.: Tamoxifen before and after orchiectomy in advanced male breast cancer. Cancer Treat. Rep. (1982) 66:1882-1883.
   PubMedGoogle Scholar
• JAIYESIMI IA, BUZDAR AU, SAHIN AA et al.: Carcinoma of the male breast. Ann. Intern. Med. (1992) 117:771-777.
   PubMed Web of Science ®Google Scholar
• LOPEZ M, DI LAURO L, PAPALDO P, LAZZARO B: Chemotherapy in metastatic male breast cancer. Oncology (1985) 42:205-209.
   PubMed Web of Science ®Google Scholar
• YAP HY, TASHIMA CK, BLUMENSCHEIN GR et al.: Chemotherapy for advanced male breast cancer. Jama (1980) 243(17):1739-1741.
   PubMed Web of Science ®Google Scholar
• ANDERSON WF, ALTHUIS MD, BRINTON LA, DEVESA PS: Is male breast cancer similar or different than female breast cancer? Breast Cancer Res. Treat. (2004) 83:77-86.
   PubMed Web of Science ®Google Scholar
• EL TAMER MB, KOMENAKA IK, TROXEL IA et al.: Men with breast cancer have better disease-specific survival than women. Arch. Surg. (2004) 139:1079-1082.
   PubMedGoogle Scholar
• SCOTT-CONNER CE, JOCHIMSEN PR, MENCK HR, WINCHESTER DJ: An analysis of male and female breast cancer treatment and survival among demographically identical pairs of patients. Surgery (1999) 126:775-780.
   PubMed Web of Science ®Google Scholar
• WILLSHER PC, LEACH IH, ELLIS IO et al.: A comparizon outcome of male breast cancer with female breast cancer. Am. J. Surg. (1997) 173:185-188.
   PubMed Web of Science ®Google Scholar
• LANGLANDS AO, MACLEAN N, KERR GR: Carcinoma of the male breast: report of a series of 88 cases. Clin. Radiol. (1976) 27:21-25.
   PubMed Web of Science ®Google Scholar
• MORGAN GW: Carcinoma of the male breast in East Anglia 1960-76. Clin. Oncol. (1979) 5:331-339.
   PubMed Web of Science ®Google Scholar
• RAVDIN PM, SIMINOFF LA, DAVIS GJ et al.: Computer program to assist in making decisions about adjvuant therapy for women with early breast cancer. J. Clin. Oncol. (2001) 19:980-991.
   PubMed Web of Science ®Google Scholar
• BOUCHARDY C, RAPITI E, FIORETTA G et al.: Undertreatment strongly decrease prognosis of breast cancer in elderly women. J. Clin. Oncol. (2003) 21:3580-3587.
   PubMed Web of Science ®Google Scholar
• GIORDANO SH, HORTOBAGYI GN, KAU SW, THERIAULT RL, BONDY ML: Breast cancer treatment guidelines in older women. J. Clin. Oncol. (2005) 23:783-791.
   PubMed Web of Science ®Google Scholar
• CUTULI B, COTTU PH, GUASTALLA JP, MECHIN H, COSTA A, JOURDAN R: A French national survey on infiltrating breast cancer: analysis of clinico-pathological features and treatment modalities in 1159 patients. Breast Cancer Res. Treat. (2006) 95:55-64.
   PubMed Web of Science ®Google Scholar
• CAZZANIGA ME, MUSTACCHI G, PRONZATO P et al.: Adjuvant systemic treatment of early breast cancer: the NORA Study. Annal. Oncol. (2006) 17:1386-1392.
   PubMed Web of Science ®Google Scholar